276 related articles for article (PubMed ID: 10077639)
1. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.
Tao W; Levine AJ
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3077-80. PubMed ID: 10077639
[TBL] [Abstract][Full Text] [Related]
2. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.
Roth J; Dobbelstein M; Freedman DA; Shenk T; Levine AJ
EMBO J; 1998 Jan; 17(2):554-64. PubMed ID: 9430646
[TBL] [Abstract][Full Text] [Related]
3. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
Joseph TW; Zaika A; Moll UM
FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168
[TBL] [Abstract][Full Text] [Related]
4. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
Boyd SD; Tsai KY; Jacks T
Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695
[TBL] [Abstract][Full Text] [Related]
5. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.
Tao W; Levine AJ
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6937-41. PubMed ID: 10359817
[TBL] [Abstract][Full Text] [Related]
6. Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation.
Migliorini D; Danovi D; Colombo E; Carbone R; Pelicci PG; Marine JC
J Biol Chem; 2002 Mar; 277(9):7318-23. PubMed ID: 11744695
[TBL] [Abstract][Full Text] [Related]
7. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.
Freedman DA; Levine AJ
Mol Cell Biol; 1998 Dec; 18(12):7288-93. PubMed ID: 9819415
[TBL] [Abstract][Full Text] [Related]
8. Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage.
Shirangi TR; Zaika A; Moll UM
FASEB J; 2002 Mar; 16(3):420-2. PubMed ID: 11790725
[TBL] [Abstract][Full Text] [Related]
9. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination.
O'Keefe K; Li H; Zhang Y
Mol Cell Biol; 2003 Sep; 23(18):6396-405. PubMed ID: 12944468
[TBL] [Abstract][Full Text] [Related]
10. MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm.
Phelps M; Phillips A; Darley M; Blaydes JP
J Biol Chem; 2005 Apr; 280(17):16651-8. PubMed ID: 15723837
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
12. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y
Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427
[TBL] [Abstract][Full Text] [Related]
13. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.
Linares LK; Hengstermann A; Ciechanover A; Müller S; Scheffner M
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12009-14. PubMed ID: 14507994
[TBL] [Abstract][Full Text] [Related]
14. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
Li M; Brooks CL; Wu-Baer F; Chen D; Baer R; Gu W
Science; 2003 Dec; 302(5652):1972-5. PubMed ID: 14671306
[TBL] [Abstract][Full Text] [Related]
15. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.
Xirodimas DP; Stephen CW; Lane DP
Exp Cell Res; 2001 Oct; 270(1):66-77. PubMed ID: 11597128
[TBL] [Abstract][Full Text] [Related]
16. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
Stürzenhofecker B; Schlott T; Quentin T; Kube D; Jung W; Trümper L
Leuk Lymphoma; 2003 Sep; 44(9):1587-96. PubMed ID: 14565663
[TBL] [Abstract][Full Text] [Related]
17. MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding.
Inoue T; Geyer RK; Howard D; Yu ZK; Maki CG
J Biol Chem; 2001 Nov; 276(48):45255-60. PubMed ID: 11572869
[TBL] [Abstract][Full Text] [Related]
18. The MDM2 RING-finger domain is required to promote p53 nuclear export.
Geyer RK; Yu ZK; Maki CG
Nat Cell Biol; 2000 Sep; 2(9):569-73. PubMed ID: 10980696
[TBL] [Abstract][Full Text] [Related]
19. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs.
Laín S; Midgley C; Sparks A; Lane EB; Lane DP
Exp Cell Res; 1999 May; 248(2):457-72. PubMed ID: 10222137
[TBL] [Abstract][Full Text] [Related]
20. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function.
Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J
Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
